Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bushen Jianpi Formula Combined with Entecavir for the Treatment of HBeAg-Negative Chronic Hepatitis B: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
Zhang JH, Zhang X, Zhou ZH, Zhu XJ, Zheng C, Li M, Jin SG, Mao DW, Xue JD, Shi WB, Chi XL, Wang XB, Li XD, Li Y, Wang H, Li Q, Zhou DQ, Wang CB, Shi CH, Li CZ, Wu JH, Kong XN, Sun XH, Gao YQ. Zhang JH, et al. Among authors: xue jd. Evid Based Complement Alternat Med. 2022 Mar 25;2022:6097221. doi: 10.1155/2022/6097221. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35368769 Free PMC article.
Chinese Herbal Medicine Combined with Entecavir for HBeAg Positive Chronic Hepatitis B: Study Protocol for a Multi-Center, Double-Blind Randomized-Controlled Trial.
Ye YA, Li XK, Zhou DQ, Chi XL, Li Q, Wang L, Lu BJ, Mao DW, Wu QK, Wang XB, Zhang MX, Xue JD, Li Y, Lu W, Guo JC, Jiang F, Zhang XW, Du HB, Yang XZ, Guo H, Gan DN, Li ZG. Ye YA, et al. Among authors: xue jd. Chin J Integr Med. 2018 Sep;24(9):653-660. doi: 10.1007/s11655-018-3011-5. Epub 2018 Sep 12. Chin J Integr Med. 2018. PMID: 30209792
Adefovir Dipivoxil plus Chinese Medicine in HBeAg-Positive Chronic Hepatitis B Patients: A Randomized Controlled 48-Week Trial.
Li XK, Zhang MX, Shao FZ, Zhou DQ, Xue JD, Liu TJ, Chi XL, Lu BJ, Wang XB, Li Q, Li J, Mao DW, Yang HS, Yang HZ, Zhao WX, Li Y, Zhang GL, Zhao YM, Zou JD, Liu MY, Zhang KK, Yang XZ, Gan DN, Li Y, Zhang P, Li ZG, Li S, Ye YA. Li XK, et al. Among authors: xue jd. Chin J Integr Med. 2020 May;26(5):330-338. doi: 10.1007/s11655-020-3250-0. Epub 2020 Jan 10. Chin J Integr Med. 2020. PMID: 31919749 Clinical Trial.
Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial.
Xiao HM, Shi MJ, Jiang JM, Cai GS, Xie YB, Tian GJ, Xue JD, Mao DW, Li Q, Yang HZ, Guo H, Lei CL, Lu W, Chen L, Liu HB, Wang J, Gao YQ, Chen JZ, Wu SD, Chen HJ, Zhao PT, Zhang CZ, Ou-Yang WW, Wen ZH, Chi XL. Xiao HM, et al. Among authors: xue jd. J Ethnopharmacol. 2022 Jul 15;293:115210. doi: 10.1016/j.jep.2022.115210. Epub 2022 Apr 7. J Ethnopharmacol. 2022. PMID: 35398501 Free article. Clinical Trial.
41 results